What is the share price of Bijoy Hans Ltd (BIJHANS) today?
The share price of BIJHANS as on 28th October 2024 is ₹23. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Bijoy Hans Ltd (BIJHANS) share?
The past returns of Bijoy Hans Ltd (BIJHANS) share are- Past 1 week: N/A%
- Past 1 month: N/A%
- Past 3 months: N/A%
- Past 6 months: N/A%
- Past 1 year: N/A%
- Past 3 years: 4.07%
- Past 5 years: 9.26%
What are the peers or stocks similar to Bijoy Hans Ltd (BIJHANS)?
The peers or stocks similar to Bijoy Hans Ltd (BIJHANS) include:What is the market cap of Bijoy Hans Ltd (BIJHANS) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Bijoy Hans Ltd (BIJHANS) is ₹6.90 Cr as of 28th October 2024.What is the 52 week high and low of Bijoy Hans Ltd (BIJHANS) share?
The 52-week high of Bijoy Hans Ltd (BIJHANS) is ₹23 and the 52-week low is ₹23.What is the PE and PB ratio of Bijoy Hans Ltd (BIJHANS) stock?
The P/E (price-to-earnings) ratio of Bijoy Hans Ltd (BIJHANS) is -57.50. The P/B (price-to-book) ratio is 2.04.Which sector does Bijoy Hans Ltd (BIJHANS) belong to?
Bijoy Hans Ltd (BIJHANS) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Bijoy Hans Ltd (BIJHANS) shares?
You can directly buy Bijoy Hans Ltd (BIJHANS) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Bijoy Hans Ltd
BIJHANS Share Price
23.000.00% (+0.00)
BIJHANS Share Price Chart
High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
How to use scorecard? Learn more
BIJHANS Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 34.50 | 2.04 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 49.39 | 6.29 | 0.54% |
BIJHANS Analyst Ratings & Forecast
Detailed Forecast —
Forecast data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
BIJHANS Company Profile
The Company offer various pharmaceutical formulations such as tablets, capsules, syrups, suspension and powders, focusing on segments such as ANTIBIOTICS, COUGH/COLD/ALLERGY, H-1RECEPTOR ANTAGONIST (ANTIULCERANT), NUTRACEUTICALS and NSAIDS
BIJHANS Similar Stocks (Peers)
Compare with peersSUNPHARMA
PE Ratio
43.78
1Y Return
15.50%
Buy Reco %
88.24
CIPLA
PE Ratio
29.62
1Y Return
12.46%
Buy Reco %
72.73
TORNTPHARM
PE Ratio
66.34
1Y Return
27.80%
Buy Reco %
68.00
MANKIND
PE Ratio
55.55
1Y Return
7.76%
Buy Reco %
81.25
DRREDDY
PE Ratio
17.34
1Y Return
2.34%
Buy Reco %
46.67
BIJHANS Forecasts
Price
Revenue
Earnings
BIJHANS Share Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeBIJHANS Company Revenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeBIJHANS Stock EPS (Earnings Per Share) Forecast
Hmm, looks like data is unavailable here. Please come back after some timeBIJHANS
Income
Balance Sheet
Cash Flow
Annual Normal View
BIJHANS Income Statement
Annual Normal View
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.69 | 1.56 | 0.69 | 0.63 | 0.73 | 0.61 | 0.48 | 0.44 | 0.58 | 1.13 | ||||||||||
Raw Materials | 0.31 | 1.22 | 0.24 | 0.23 | 0.32 | 0.33 | 0.22 | 0.18 | 0.23 | 0.89 | ||||||||||
| Power & Fuel Cost | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | |||||||||||
| Employee Cost | 0.13 | 0.17 | 0.18 | 0.17 | 0.17 | 0.17 | 0.17 | 0.18 | 0.16 | |||||||||||
| Selling & Administrative Expenses | 0.22 | 0.24 | 0.18 | 0.18 | 0.19 | 0.16 | 0.19 | 0.19 | 0.22 | |||||||||||
| Operating & Other expenses | -0.01 | -0.05 | 0.10 | 0.04 | 0.03 | -0.01 | 0.03 | 0.24 | 0.00 | |||||||||||
EBITDA | 0.02 | -0.04 | -0.03 | -0.01 | 0.00 | -0.06 | -0.15 | -0.37 | -0.06 | 0.24 | ||||||||||
| Depreciation/Amortization | 0.07 | 0.07 | 0.08 | 0.06 | 0.05 | 0.04 | 0.03 | 0.06 | 0.05 | 0.03 | ||||||||||
| PBIT | -0.05 | -0.11 | -0.11 | -0.07 | -0.05 | -0.10 | -0.18 | -0.43 | -0.11 | 0.21 | ||||||||||
| Interest & Other Items | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | ||||||||||
| PBT | -0.05 | -0.11 | -0.12 | -0.07 | -0.05 | -0.10 | -0.18 | -0.44 | -0.12 | 0.20 | ||||||||||
| Taxes & Other Items | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||||||
| Net Income | -0.05 | -0.11 | -0.11 | -0.07 | -0.05 | -0.10 | -0.18 | -0.44 | -0.12 | 0.20 | ||||||||||
| EPS | -0.17 | -0.37 | -0.37 | -0.23 | -0.17 | -0.33 | -0.60 | -1.47 | -0.40 | 0.67 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
BIJHANS Company Updates
FY 2015
Annual report
PDFFY 2016
Annual report
PDFFY 2017
Annual report
PDFFY 2018
Annual report
PDFFY 2019
Annual report
PDFFY 2020
Annual report
PDFFY 2021
Annual report
PDFFY 2022
Annual report
PDFFY 2023
Annual report
PDFFY 2024
Annual report
PDFBIJHANS Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Bijoy Hans Ltd | -57.50 | 2.04 | — |
| Sun Pharmaceutical Industries Ltd | 43.78 | 6.25 | 0.77% |
| Cipla Ltd | 29.62 | 4.55 | 0.86% |
| Torrent Pharmaceuticals Ltd | 66.34 | 16.03 | 0.86% |
BIJHANS Stock Price Comparison
Compare BIJHANS with any stock or ETFCompare BIJHANS with any stock or ETF
BIJHANS
BIJHANS Shareholdings
BIJHANS Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
BIJHANS Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
BIJHANS Shareholding Pattern
BIJHANS Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing BIJHANS stock
Looks like this stock is not in any smallcase yet.
BIJHANS Events
BIJHANS Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
BIJHANS has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
BIJHANS Dividends
Hmm, looks like data is unavailable here. Please come back after some timeBIJHANS Stock News & Opinions
Articles & Videos
Corporate
Bijoy Hans to conduct board meeting
Bijoy Hans will hold a meeting of the Board of Directors of the Company on 28 March 2025.Powered by Capital Market - Live
4 weeks agoCapital Market - Live
Earnings
Bijoy Hans reports standalone net profit of Rs 0.53 crore in the December 2024 quarter
Net profit of Bijoy Hans reported to Rs 0.53 crore in the quarter ended December 2024 as against net loss of Rs 0.04 crore during the previous quarter ended December 2023. Sales rose 85.71% to Rs 0.13 crore in the quarter ended December 2024 as against Rs 0.07 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales0.130.07 86 OPM %-53.85-100.00 - PBDT-0.02-0.02 0 PBT-0.03-0.04 25 NP0.53-0.04 LP Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Bijoy Hans to table results
Bijoy Hans will hold a meeting of the Board of Directors of the Company on 4 February 2025.Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Bijoy Hans announces board meeting date
Bijoy Hans will hold a meeting of the Board of Directors of the Company on 7 January 2025.Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Bijoy Hans EGM scheduled
Bijoy Hans announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 24 January 2025.Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Bijoy Hans to conduct board meeting
Bijoy Hans will hold a meeting of the Board of Directors of the Company on 26 December 2024.Powered by Capital Market - Live
3 months agoCapital Market - Live
Earnings
Bijoy Hans reports standalone net loss of Rs 0.14 crore in the September 2024 quarter
Net Loss of Bijoy Hans reported to Rs 0.14 crore in the quarter ended September 2024 as against net loss of Rs 0.05 crore during the previous quarter ended September 2023. Sales declined 14.29% to Rs 0.06 crore in the quarter ended September 2024 as against Rs 0.07 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales0.060.07 -14 OPM %-283.33-114.29 - PBDT-0.13-0.03 -333 PBT-0.14-0.05 -180 NP-0.14-0.05 -180 Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Bijoy Hans to declare Quarterly Result
Bijoy Hans will hold a meeting of the Board of Directors of the Company on 9 November 2024Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Bijoy Hans to conduct board meeting
Bijoy Hans will hold a meeting of the Board of Directors of the Company on 8 October 2024.Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Bijoy Hans to conduct AGM
Bijoy Hans announced that the 39th Annual General Meeting (AGM) of the company will be held on 27 September 2024.Powered by Capital Market - Live
7 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of -1.64%, vs industry avg of 9.04%
Over the last 5 years, market share stayed at 0%